Correction to: HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8+ T and NK cells: a novel therapeutic tumour vaccine

Detalles Bibliográficos
Autores principales: Yu, Zhaojin, Liu, Wensi, He, Ying, Sun, Mingli, Yu, Jiankun, Jiao, Xue, Han, Qiang, Tang, Haichao, Zhang, Bing, Xian, Yunkai, Qi, Jing, Gong, Jing, Xin, Wang, Shi, Gang, Shan, Fengping, Zhang, Rui, Li, Jianping, Wei, Minjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482666/
https://www.ncbi.nlm.nih.gov/pubmed/34587994
http://dx.doi.org/10.1186/s13045-021-01176-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482666/
https://www.ncbi.nlm.nih.gov/pubmed/34587994
http://dx.doi.org/10.1186/s13045-021-01176-1

Ejemplares similares